Novel Antiplatelet Agent Use for Acute Coronary Syndrome in the Emergency Department: A Review.

Conclusion. The use of ticagrelor and prasugrel as first line ED treatment of ACS is not well established. Current evidence supports the use of several agents with the final decision based on treatment protocols conjointly developed between cardiology and emergency medicine (EM). Further clinical trials involving head-to-head trials or comparisons of drug-based strategies are required to show superiority in reducing cardiac endpoints with regard to ED initiation of treatment. PMID: 23509665 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/PubMed/23509665?dopt=Abstract

Source: Cardiology Research and Practice - March 20, 2013 Category: Cardiology Authors: Curial M, Nath E, Lang E Tags: Cardiol Res Pract Source Type: research